-
The Hong Kong Tiananmen vigil activists convicted in national security trial
-
Australia's Hussey mulls role with England for Ashes series
-
Eel-powered Japan whizz-kid, 11, chases Asian Games history
-
Indian captain 'scapegoat' in Britain's Russia shadow fleet case, wife says
-
Asian markets extend rally as traders assess US Treasuries pledge
-
Rosenior seeks to match Paris FC's capital ambition as Ligue 1 returns
-
Barcelona enter new era as Flick targets La Liga hat-trick
-
Inter set for Serie A title defence as Milan get Amorim reboot
-
Pogacar favourite for Vuelta with Grand Tour treble in sight
-
'Greatest' Springboks face All Blacks in clash of juggernauts
-
Bangladesh coach Simmons wary of Australia backlash in second Test
-
William and Harry: Britain's warring royal brothers
-
Hong Kong Tiananmen activists to receive national security verdict
-
UN holds second informal poll for next leader
-
Who are the candidates vying to lead the UN?
-
In US mining hub, black lung rates soar
-
Swiatek into Cincinnati semis after Rybakina injury
-
Champions Arsenal embrace being 'hunted' as Premier League returns
-
University suspends academic behind Jason Arday plagiarism charges
-
World No.2 Rybakina retires from Cincinnati clash with Swiatek
-
Key European leaders demand Israel halt West Bank settlement project
-
'I heard you missed me': Melania Trump jokes about month out of spotlight
-
Kiwi Ears Stardust: The Art of Natural Balance
-
IRA-Eligible Gold: Rules, Approved Coins, and Best Gold Dealers (Guide Released)
-
McIlroy bounces back to share BMW Championship lead
-
Amazon Prime Video to invest $2 bn in Latin America productions
-
Cobolli fueled by candy in sweet defeat of Paul
-
Panama Canal to reduce shipping over El Nino-fueled drought
-
Jailed Pakistan ex-PM Khan moved to hospital on court order: party
-
Maradona trial on hold over possible medical evidence mix-up
-
Pogacar eyes 'missing' piece ahead of Vuelta return
-
'Green dilemma': China's solar boom hurt birds, says study
-
US, Canada 'very close' to trade deal, Ottawa says, as details emerge
-
Pegula hangs on to dispatch Anisimova, reach Cincinnati semi-finals
-
Ronaldinho returns in search of 'beautiful' 300th goal
-
US charges woman with IS-inspired plot to blow up New York State Capitol
-
US pushes allies, China to back Trump's economic war on Iran
-
What a record-breaking El Nino could mean for the world
-
Former NBA MVP Harden reportedly set to return to Cavaliers
-
Duplantis edges Karalis to win Lausanne Diamond League pole vault
-
Brook makes Pakistan pay for drop as England dominate first Test
-
Alcaraz to return for US Open title defence
-
MemeCore Arrives on Nasdaq Through $1 Billion Landmark Treasury Transaction
-
China's rapid solar expansion hurt bird diversity: study
-
First US deportees land in Liberia
-
President Paul Biya back in Cameroon after 73 days away
-
US, Canada resume talks to finalize trade deal as details emerge
-
Newcastle boss Jaissle unfazed by lack of respect
-
Europe heatwaves scorch 80 million with 40 C heat: AFP analysis
-
US Open purse to top $100 mn as Grand Slams form player council
MDCE Targets $5 Trillion Global Agriculture Market with StrainScan Pro Enterprise Deployment on iPad Air (OTC Pink:MDCE)
Proprietary AI Vision Platform Designed for On-Device Quality Grading and Produce Inspection Across Farming and Post-Harvest Operations
MESA, AZ / ACCESS Newswire / August 10, 2026 / Medical Care Technologies Inc. (OTC PINK:MDCE) today highlighted the expansion of its StrainScan Pro platform into agricultural quality control, positioning the proprietary AI vision software for enterprise deployment on iPad Air devices across farming and post-harvest operations.

Global agricultural production represents one of the world's largest economic sectors, with production value measured in the multi-trillion-dollar range and estimated near $5 trillion. Within this vast market, the need for consistent, rapid, and scalable visual quality grading and inspection continues to grow as producers, packers, and distributors seek greater efficiency and reduced loss.
StrainScan Pro leverages Medical Care Technologies' proprietary AI vision technology to deliver on-device visual analysis. The platform is designed for installation on iPad Air devices, enabling portable, enterprise-ready deployment without the need for complex fixed infrastructure. This approach allows operators to perform quality grading and produce inspection directly in the field, at packing facilities, or during post-harvest handling.
"The agricultural sector presents an enormous opportunity for practical AI vision tools," said Marshall Perkins, CEO of Medical Care Technologies. "By delivering StrainScan Pro as a proprietary software solution optimized for iPad Air, we are making advanced visual quality control accessible and scalable for enterprise clients. The same core technology that powers our other applications is now being positioned to address real needs across one of the largest markets in the world."
Investors and industry participants can learn more about the agricultural applications of the platform at: https://strainscanpro.com/industries/agriculture
The move into agriculture continues Medical Care Technologies' strategy of deploying its AI vision capabilities across high-value verticals while maintaining revenue generation through subsidiaries Infinite Auctions and Real Game Used.
About Medical Care Technologies Inc. Medical Care Technologies Inc. (OTC PINK:MDCE) is a diversified technology company focused on the development and commercialization of artificial intelligence-powered applications spanning health, wellness, nutrition, lifestyle, and enterprise imaging analysis solutions. The Company also owns subsidiaries Infinite Auctions and Real Game Used, which provide complementary revenue-generating operations. Visit: https://medicalcaretechnologies.com
Safe Harbor Statement This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are based on current expectations and assumptions, and actual results may differ materially due to various risks and uncertainties. The company undertakes no obligation to update these statements except as required by law. Investors are cautioned not to place undue reliance on forward-looking statements.
Contact Information: Medical Care Technologies Inc. 1910 S. Stapley Drive, Suite 221, Mesa, AZ 85204 Phone: +1 (480) 645-0750 Email: [email protected] Websites: https://medicalcaretechnologies.com | https://strainscanpro.com
SOURCE: Medical Care Technologies Inc.
View the original press release on ACCESS Newswire
F.Wilson--AT